Artificial intelligence will likely play a crucial role in shaping the future of medicine. Renowned venture investor Jim Breyer explores the many possibilities of this promising technology in conversation with Burda Media CEO Paul-Bernhard Kallen. One of the prospects is combining top talent from Silicon Valley companies with the expertise of medical companies, which is already “leading to an explosion of very positive opportunities around AI in medicine”, Breyer says.
DLD Video
Healthcare and AI
By loading the video you agree to the Privacy Policy of YouTube and accept that your data will be processed by Google.
Speakers
Jim Breyer
Breyer Capital
Jim is the Founder and CEO of Breyer Capital, a premier venture capital firm based in Austin, TX and Menlo Park, CA. Jim has been an early investor in over 40 technology companies that have completed highly successful public offerings or mergers. He has served as an investor/lead Director at 21st Century Fox, Dell, Etsy, Facebook, Marvel Entertainment, Wal-Mart, and many other highly successful technology companies.
Paul-Bernhard Kallen
Hubert Burda Media
Dr. Paul-Bernhard Kallen joined the family-owned company Hubert Burda Media in 1996, initially as Managing Director for corporate finance, administration, personnel and of Burda’s international publishing holding. holds Master and Ph.D. degrees in Economics. He has been CEO since 2010.
More DLD Talks
Human-centered AI
Traditional user-centered design isn’t sufficient for AI systems, as they become ubiquitous in our everyday lives, computer scientist James Landay, Co-Director of the Stanford Institute for Human-centered Artificial Intelligence (HAI), argues in his…
Video Details
Future Positive – or Not? Tech for Sustainable Mobility
In this DLD25 session, automobile industry leaders and scientists discuss the challenges and opportunities of sustainable mobility in the face of climate change. Andreas Urschitz of Infineon Technologies hosts a panel with political…
Video Details